Gefitinib frequently induces liver damage in patients with lung adenocarcinoma previously treated by chemotherapy
Yasoo Sugiura,1 Etsuo Nemoto,1 Osamu Kawai,2 Yasuyuki Ohkubo,2 Hisae Fusegawa,2 Shizuka Kaseda1 1Department of Pulmonary and Thoracic Surgery, 2Department of Respiratory Medicine, Kanagawa National Hospital, Hadano, Japan Background: Gefitinib is known as one of the agents for treating patients with...
Guardado en:
Autores principales: | Sugiura Y, Nemoto E, Kawai O, Ohkubo Y, Fusegawa H, Kaseda S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/78374b2549a942babf80989947c6b5ba |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Salvage Chemotherapy in Patients with Previously Treated Thymic Carcinoma
por: Kyoichi Kaira, et al.
Publicado: (2021) -
Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR status
por: Hong Jian, et al.
Publicado: (2017) -
Glycyrol Alone or in Combination with Gefitinib Is Effective against Gefitinib-Resistant HCC827GR Lung Cancer Cells
por: Shuang Zhao, et al.
Publicado: (2021) -
High quality of 58-month life in lung cancer patient with brain metastases sequentially treated with gefitinib and osimertinib
por: Zhang Ying, et al.
Publicado: (2021) -
A pilot study of a metronomic chemotherapy regimen with weekly low-dose docetaxel for previously treated non-small cell lung cancer
por: Yokoi T, et al.
Publicado: (2012)